Fibrolamellar hepatocellular carcinoma

The names of the lead clinicians for the IRCI Fibrolamellar hepatocellular carcinoma group include:

Dr Michel Ducreux (EORTC)
Dr Marcio Malogolowkin (US)
Dr Tim Meyer (UK)

Informative websites

The fibrolamellar hepatocellular carcinoma group has decided that there is no immediate role for an interventional trial but instead are undertaking preparatory work outwith IRCI.

Rare Cancer Types

Active groups

: Gynaecological sarcoma

: Penile cancer

: Rare melanoma

: Relapsed/metastatic anal cancer

: Salivary gland cancer

: Small bowel adenocarcinoma

: Merkel Cell Carcinoma

Closed groups

: Anaplastic thyroid cancer

: Desmoplastic small round cell tumour

: Fibrolamellar hepatocellular carcinoma

: Rare brain cancer

: Thymoma